IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v553y2018i7689d10.1038_nature25183.html
   My bibliography  Save this article

The biology and management of non-small cell lung cancer

Author

Listed:
  • Roy S. Herbst

    (Yale Cancer Center, Yale School of Medicine)

  • Daniel Morgensztern

    (Washington University School of Medicine)

  • Chris Boshoff

    (Yale Cancer Center, Yale School of Medicine
    Pfizer, Inc)

Abstract

Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been achieved over the past two decades, increasing our understanding of the disease biology and mechanisms of tumour progression, and advancing early detection and multimodal care. The use of small molecule tyrosine kinase inhibitors and immunotherapy has led to unprecedented survival benefits in selected patients. However, the overall cure and survival rates for NSCLC remain low, particularly in metastatic disease. Therefore, continued research into new drugs and combination therapies is required to expand the clinical benefit to a broader patient population and to improve outcomes in NSCLC.

Suggested Citation

  • Roy S. Herbst & Daniel Morgensztern & Chris Boshoff, 2018. "The biology and management of non-small cell lung cancer," Nature, Nature, vol. 553(7689), pages 446-454, January.
    • Handle: RePEc:nat:nature:v:553:y:2018:i:7689:d:10.1038_nature25183
    DOI: 10.1038/nature25183
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature25183
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature25183?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Xiang Ge Luo & Jack Kuipers & Niko Beerenwinkel, 2023. "Joint inference of exclusivity patterns and recurrent trajectories from tumor mutation trees," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    2. Michael J. P. Crowley & Bhavneet Bhinder & Geoffrey J. Markowitz & Mitchell Martin & Akanksha Verma & Tito A. Sandoval & Chang-Suk Chae & Shira Yomtoubian & Yang Hu & Sahil Chopra & Diamile A. Tavarez, 2023. "Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    3. Feras E. Machour & Enas R. Abu-Zhayia & Joyce Kamar & Alma Sophia Barisaac & Itamar Simon & Nabieh Ayoub, 2024. "Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    4. Wei Jiang & Qitao Yu, 2019. "LKB1, a Key Driver Gene of Human Lung Squamous Cell Carcinoma," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 19(3), pages 14335-14336, July.
    5. Meng Nie & Ke Yao & Xinsheng Zhu & Na Chen & Nan Xiao & Yi Wang & Bo Peng & LiAng Yao & Peng Li & Peng Zhang & Zeping Hu, 2021. "Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    6. Chen Ni & Xiaohan Lou & Xiaohan Yao & Linlin Wang & Jiajia Wan & Xixi Duan & Jialu Liang & Kaili Zhang & Yuanyuan Yang & Li Zhang & Chanjun Sun & Zhenzhen Li & Ming Wang & Linyu Zhu & Dekang Lv & Zhih, 2022. "ZIP1+ fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn2+ transfer," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    7. Xiaobo Yang & Zhilong Mi & Qingcai He & Binghui Guo & Zhiming Zheng, 2023. "Identification of Vital Genes for NSCLC Integrating Mutual Information and Synergy," Mathematics, MDPI, vol. 11(6), pages 1-15, March.
    8. Yu-Yang Bi & Qiu Chen & Ming-Yuan Yang & Lei Xing & Hu-Lin Jiang, 2024. "Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer," Nature Communications, Nature, vol. 15(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:553:y:2018:i:7689:d:10.1038_nature25183. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.